click on circles to display study description...
budesonide (n=1073) vs. standard of care (n=1988)
randomized controlled trial
inhaled budesonide (800μg twice daily for 14 days) plus usual care Inhaled budesonide (800μg twice daily for 14 days) plus usual care;
usual care
several arms: usual care, usual care plus budesonide or usual care plus other interventions
COVID 19 outpatients
Open-label.
United Kingdom.
powered by vis.js Network
An extraction panel is open